Olema Pharmaceuticals, Inc. OLMA Return on equity

Return on equity at other companies

Eli LillyLLY

102.4%+15.7pp

LON

LeonaBio, Inc.LONA

-298.8%-726pp

Oric Pharmaceuticals, Inc.ORIC

-42.6%-4.6pp

Opko HealthOPK

-5.9%-2.1pp

Stoke Therapeutics, Inc.STOK

-45.6%-66.1pp

IDEAYA Biosciences, Inc.IDYA

-14.3%-5.0pp

FAQ

What is Olema Pharmaceuticals, Inc.'s return on equity?

Olema Pharmaceuticals, Inc. (OLMA) reported return on equity of -42.9% in Q1 2026.

How has Olema Pharmaceuticals, Inc.'s return on equity changed year-over-year?

Olema Pharmaceuticals, Inc.'s return on equity decreased by 3.1% year-over-year, from -41.6% to -42.9%.

What is the long-term trend for Olema Pharmaceuticals, Inc.'s return on equity?

Over 4 years (2021 to 2025), Olema Pharmaceuticals, Inc.'s return on equity has grown at a 12.5% compound annual growth rate (CAGR), from -22.8% to -36.6%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.